Syndrome News and Research

RSS

Most effective treatment for excessive daytime sleepiness found

McMaster University researchers Dena Zeraatkar and Tyler Pitre have found that the drug solriamfetol is the most effective treatment for excessive daytime sleepiness (EDS) for people with obstructive sleep apnea (OSA).

9 May 2023

Study reports cost-effectiveness of population genetic testing

An exhaustive cost-benefit analysis of population genetic testing published in Annals of Internal Medicine concludes with a recommendation to U.S. health policymakers to adopt routine testing of adults ages 40 and under for three genetic conditions posing high risk of life-threatening illness.

9 May 2023

Experts urge increased attention to the threat of climate change and pollution on children's health

Study explores the impact of climate change and environmental chemicals on children's health.

9 May 2023

Legal pot is more potent than ever — and still largely unregulated

Marijuana and other products containing THC, the plant's main psychoactive ingredient, have grown more potent and more dangerous as legalization has made them more widely available.

9 May 2023

Household transmission of endemic human coronaviruses in the US

Researchers describe clinical outcomes of endemic human coronavirus household transmission.

9 May 2023

An evaluation of the timeliness of COVID-19 surveillance data sources and indicators

Researchers evaluated correlations and timeliness of COVID-19 surveillance data sources.

9 May 2023

SARS-CoV-2 infection leads to higher IgA levels in breast milk than vaccination

Researchers explore the presence and effectiveness of SARS-CoV-2 antibodies in breastmilk following infection, vaccination, or both.

8 May 2023

Cognitive behavioral therapy is beneficial for individuals with post-viral fatigue after COVID-19

Those with post-viral fatigue after suffering from COVID-19 benefit from cognitive behavioral therapy, resulting in less fatigue and concentration problems.

8 May 2023

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain

Researchers highlighted the pace of development of COVID-19 therapies during the pandemic and the challenges that hinder the widespread availability of anticoronavirals.

8 May 2023

Is there a risk of menstrual disturbance and bleeding after SARS-CoV-2 vaccination in pre-and post-menopausal females?

A recent study evaluated the risks of menstrual disturbance and bleeding after SARS-CoV-2 vaccination in pre- or post-menopausal females.

8 May 2023

Hay fever could be triggering other allergies, doctor reveals

Hay fever may be triggering an allergic reaction to foods such as fruits, vegetables, nuts and legumes, a doctor from a digital healthcare provider has revealed.

8 May 2023

Omicron's grip on Sweden: High transmission rates persist despite high seroprevalence

Research paper reports on a study conducted in Sweden to determine the prevalence of SARS-CoV-2 Omicron infection despite high seroprevalence. The study found a high prevalence of SARS-CoV-2 Omicron infection in Sweden despite high seroprevalence.

7 May 2023

The safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccine

Research paper reports the results of a phase 3 clinical trial evaluating the efficacy and safety of the FINLAY-FR-2 and FINLAY-FR-1A vaccines in Iranian adults.

7 May 2023

The impact of living in a ‘food desert’ on metabolic health during pregnancy

Research paper investigates the relationship between socioeconomic status (SES), food desert severity, and metabolic health during pregnancy. The study found that lower SES predicted higher food desert severity, which in turn predicted higher percent adiposity during the second trimester of pregnancy.

7 May 2023

Combination treatment shows promise for aggressive subtype of non-Hodgkin lymphoma

Nearly 90 percent of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.

5 May 2023

Syndrome News and Research

Most effective treatment for excessive daytime sleepiness found

Study reports cost-effectiveness of population genetic testing

Experts urge increased attention to the threat of climate change and pollution on children's health

Legal pot is more potent than ever — and still largely unregulated

Household transmission of endemic human coronaviruses in the US

An evaluation of the timeliness of COVID-19 surveillance data sources and indicators

SARS-CoV-2 infection leads to higher IgA levels in breast milk than vaccination

Cognitive behavioral therapy is beneficial for individuals with post-viral fatigue after COVID-19

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain

Is there a risk of menstrual disturbance and bleeding after SARS-CoV-2 vaccination in pre-and post-menopausal females?

Hay fever could be triggering other allergies, doctor reveals

Omicron's grip on Sweden: High transmission rates persist despite high seroprevalence

The safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccine

The impact of living in a ‘food desert’ on metabolic health during pregnancy

Combination treatment shows promise for aggressive subtype of non-Hodgkin lymphoma

Lead contamination surfaces in affluent Atlanta neighborhood

Did race/ethnicity disparities in severe COVID-19 outcomes persist in the era of vaccination?

Wistar scientists uncover a key mechanism as to how p53 suppresses tumors

Evaluating the effectiveness of both BA.1-containing and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines

Four important signs that signal increased risk of early-onset colorectal cancer identified

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News